Preventing Platelet Thrombosis With a PAR1 Pepducin

被引：5
|
作者：
Abdel-Latif, Ahmed
Smyth, Susan S. [1 ]
机构：
[1] Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA
来源：
CIRCULATION | 2012年 / 126卷 / 01期
关键词：
Editorials; platelet aggregation; thrombosis; G protein coupled receptor; PAR1; thrombin; ACUTE CORONARY SYNDROMES; CONTROLLED PHASE-II; DOUBLE-BLIND; ANTAGONIST; SAFETY; RISK; TOLERABILITY; VORAPAXAR; ATOPAXAR; EVENTS;
D O I：
10.1161/CIRCULATIONAHA.112.122317
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 15
页数：3
相关论文
共 50 条
  • [31] Irreversible platelet activation requires PAR1 regulation of phosphatidylinositol phosphates (PIPns) activation of Rap1
    Holinstat, Michael
    Hudson, W. James
    Preininger, Anita M.
    Hamm, Heidi E.
    BLOOD, 2007, 110 (11) : 40B - 40B
  • [32] Recombination in the Human Pseudoautosomal Region PAR1
    Hinch, Anjali G.
    Altemose, Nicolas
    Noor, Nudrat
    Donnelly, Peter
    Myers, Simon R.
    PLOS GENETICS, 2014, 10 (07):
  • [33] Exploration of a new series of PAR1 antagonists
    Planty, Bruno
    Pujol, Chantal
    Lamothe, Marie
    Maraval, Catherine
    Horn, Clemens
    Le Grand, Bruno
    Perez, Michel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1735 - 1739
  • [34] Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation
    Pouget, Thomas
    Pillois, Xavier
    Fiore, Mathieu
    THROMBOSIS RESEARCH, 2019, 173 : 151 - 154
  • [35] PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact
    Judge, Heather M.
    Jennings, Lisa K.
    Moliterno, David J.
    Hord, Edward
    Ecob, Rosemary
    Tricoci, Pierluigi
    Rorick, Tyrus
    Kotha, Jayaprakash
    Storey, Robert F.
    PLATELETS, 2015, 26 (03) : 236 - 242
  • [36] Activation of either PAR1 or PAR4 on human platelets can elicit expression of maximum platelet procoagulant activity.
    Heger, CD
    Mosley, CN
    Tracy, PB
    BLOOD, 2001, 98 (11) : 518A - 518A
  • [37] Platelet-platelet fusion results from fusing of plasma membranes and is augmented by stimulation through PAR1 or CCR4
    Woronowicz, Kamil
    Rozenvayn, Nataliya
    Flaumenhaft, Robert
    BLOOD, 2007, 110 (11) : 48A - 49A
  • [38] Par1 and par6 homologs in the leech Helobdella robusta.
    Ren, XY
    Weisblat, DA
    DEVELOPMENTAL BIOLOGY, 2003, 259 (02) : 501 - 501
  • [39] PAR genes (PAR1 & 2): Probes for pathological assessment and targets for therapy
    Bar-Shavit, Rachel
    Kancharla, Arun
    Jaber, Mohammad
    Agranovitch, Daniel
    Maoz, Myriam
    Maly, Bella
    Peretz, Tamar
    Uziely, Beatrice
    TUMOR BIOLOGY, 2012, 33 : 15 - 15
  • [40] Developing PAR1 Antagonists: Minding the Endothelial Gap
    Ramachandran, Rithwik
    DISCOVERY MEDICINE, 2012, 13 (73) : 425 - 431
12345